von Tobias Borgers | Okt 27, 2019 | Merck
Globaler DNA / RNA-Extraktionsmarkt 2019-2025 Qiagen, Merck Millipore, Agilent Technologies, Bio-Rad EUWID Facility Management Link zum Originalbeitrag
von Tobias Borgers | Okt 27, 2019 | Roche
Media Release Basel, 05 March 2019 Roche Annual General Meeting 2019 All proposals of the Board of Directors approved Christoph Franz as Chairman of the Roche Board of Directors and all other Board members standing for re-election approved; Professor Dr Hans Clevers...
von Tobias Borgers | Okt 27, 2019 | Glaxo
Bowen Hanes & Co Inc increased its stake in Glaxosmithkline Plc Adr (Gb) (GSK) by 9.6% based on its latest 2019Q2 regulatory filing with the SEC. Bowen Hanes & Co Inc bought 67,675 shares as the company’s stock rose 2.15% . The institutional investor held...
von Tobias Borgers | Okt 27, 2019 | Boehringer
Lauren Sullivan of Epstein Becker Green. Epstein Becker Green Hires Lauren Sullivan Epstein Becker Green in Stamford has announced the hire of Lauren Sullivan, a former health care and pharmaceutical executive with more than 15 years of experience, in the firm’s...
von Tobias Borgers | Okt 20, 2019 | Bayer
Bayer will invest more than $30 million over the next five years to fund collaborative research projects focused on finding new treatments for chronic lung diseases, including chronic obstructive pulmonary disease (COPD). The projects will be developed in a new lab...
von Tobias Borgers | Okt 11, 2019 | Roche
Media Release Basel, 25 July 2019 Roche reports very strong performance in the first half of 2019 – Outlook raised Group sales increase 9%1 at constant exchange rates and 8% in Swiss francs Pharmaceuticals Division sales up 10%, driven mainly by Ocrevus, Hemlibra,...
